CareDx To Participate in the Raymond James & Associates' 44th Annual Institutional Investors Conference
06.03.2023 - CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company ...
Source: wallstreet-online.de